期刊文献+

浅析导致心肌梗死患者发生肺部感染的危险因素

下载PDF
导出
摘要 目的:分析导致心肌梗死患者发生肺部感染的危险因素。方法:选取2014年5月至2016年7月期间在河北省唐山市第三医院接受治疗的243例心肌梗死患者作为研究对象。对其临床资料进行回顾性分析。根据是否发生肺部感染将其分为感染组(47例)和对照组(196例)。对比两组患者的各项临床资料,从中找出导致心肌梗死患者发生肺部感染的危险因素。结果:感染组患者中合并有高血压患者的比率、合并有糖尿病患者的比率、病情严重程度为重度患者的比率均高于对照组患者,差异具有统计学意义(P<0.05)。结论:导致心肌梗死患者发生肺部感染的危险因素主要包括其合并有糖尿病或高血压、病情较为严重等。临床医生应对上述情况予以关注。
出处 《当代医药论丛》 2018年第8期116-117,共2页
  • 相关文献

参考文献3

二级参考文献31

  • 1张敏,李健,蔡乙明,马虹.急性心肌梗死后合并心源性休克的相关危险因素分析[J].环境与职业医学,2007,24(3):265-267. 被引量:6
  • 2Dolgikh TI, Kaftyreva LA, Votovich MA, et al. Verotoxin asa major laboratory criterion for Escherichia coliO157-in- ducedenteric infection complicated by hemolytic uremic syn- drome ininfants in the Omsk region[J']. Klin Lab Diagn, 2010, 8,52-53.
  • 3Plesinac-Karapandzic V,Masulovic D,Markovic B,etal. Per- cutaneous nephrostomy in the management of advanced andt- erminal-stage gynecologic malignancies: outcome and compli- cations[J]. Eur J Gynaecol Oncol, 2010,31 (6) : 645-650.
  • 4Goldberg RJ,Spencer FA,Gore JM. Thirty-year trends (1975 to 2005) in the magnitude of,management of,and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction:a population-based perspective[J].Circulation,2009,(9):1211-1219.doi:10.1161/CIRCULATIONAHA.108.814947.
  • 5Holmes DR Jr,Bates ER,Kleiman NS. Contemporary reperfusion therapy for cardiogenic shock:the GUSTO-Ⅰ trial experience.The GUSTO-I Investigators.Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries[J].Journal of the American College of Cardiology,1995.668-674.
  • 6Hochman JS,Buller CE,Sleeper LA. Cardiogenic shock complicating acute myocardial infarction-etiologies,management and outcome:a report from the SHOCK Trial Registry.Should we emergently revascularize Occluded Coronaries for cardiogenic shock[J].Journal of the American College of Cardiology,2000.1063-1070.
  • 7Yusuf S,Mehta SR,Díaz R. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings:the CREATE and ECLA trial program evaluating GIK (glucose,insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction[J].American Heart Journal,2004.1068-1078.
  • 8Hasdai D,Harrington RA,Hochman JS. Platelet glycoprotein Ⅱ b/Ⅲ a blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation[J].Journal of the American College of Cardiology,2000.685-692.
  • 9The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Ⅱ b investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes[J].New England Journal of Medicine,1996.775-782.
  • 10Goldberg RJ,Samad NA,Yarzebski J. Temporal trends in cardiogenic shock complicating acute myocardial infarction[J].New England Journal of Medicine,1999.1162-1168.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部